Trial intelligence / Profile preview

Azithromycin vs Doxycycline for Pediatric Mycoplasma Pneumonia

NCT03911440Unknown

Sponsor
National Taiwan University Hospital
Start
Nov 2018
Primary completion
Dec 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of doxycycline in atypical pneumonia (2 arms), sponsored by National Taiwan University Hospital. Primary endpoint: Defervescence at 10 days. Status: unknown.

02

Drugs

doxycycline
03

Conditions

atypical pneumonia

Beyond the preview

Go deeper on NCT03911440.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03911440.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call